|Articles|May 10, 2016

CDC Updates Zika Diagnostic Testing Guidance

Today, the Centers for Disease Control and Prevention (CDC) updated its interim diagnostic testing guidance for Zika virus in public health laboratories based on preliminary data demonstrating that Zika virus can be found at higher levels or for longer duration in urine than in serum (blood):

• Zika virus rRT-PCR should be performed on urine collected ≤14 days after illness onset.
• Zika virus rRT-PCR should continue to be performed on serum specimens collected <7 days after illness onset.
• A positive Zika rRT-PCR result is evidence of a current Zika virus infection.
• Because viremia decreases over time and dates of illness onset may not be accurately reported, a negative rRT-PCR does not exclude Zika virus infection, and IgM antibody testing should be performed.

The CDC will continue to update this guidance because these data are preliminary and additional rRT-PCR data will become available. For more information about this guidance, see: Interim Guidance for Zika Virus Testing of Urine - United States, 2016/.

Source: CDC


Related to this article

Infection preventionists in full PPE with children in DRC.  (Image credit: author with AI)
Nearly 4 months into the DRC's Bundibugyo virus disease outbreak, some indicators suggest transmission may be slowing. But shifting hotspots, treatment-center capacity problems, community deaths, and incomplete surveillance data show why national case totals alone cannot determine whether containment has been achieved.